Shanghai Pharmaceutical announced more specific information about its upcoming Hong Kong IPO. The event has been scheduled for April and will raise up to $1.2 billion. The company reportedly plans to issue 667 million H shares, representing 25% of its expanded equity. As underwriters of the offering, Shanghai Pharma has hired Credit Suisse, Deutsche Bank, Golden Sachs and CICC. More details....

Stock Symbol: (SHA: 601607)     Share this with colleagues: